TRIB
Trinity Biotech
TRIB
TRIB
71 hedge funds and large institutions have $109M invested in Trinity Biotech in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 16 increasing their positions, 21 reducing their positions, and 25 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
50% less capital invested
Capital invested by funds: $220M → $109M (-$111M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $162K
Holders
71
Holding in Top 10
2
Calls
–
Puts
$162K
Top Buyers
| 1 | +$6.11M | |
| 2 | +$5.11M | |
| 3 | +$3.22M | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$3.02M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
+$1.83M |
Top Sellers
| 1 | -$12.9M | |
| 2 | -$11.3M | |
| 3 | -$6.57M | |
| 4 |
PCA
Prospect Capital Advisors
Sausalito,
California
|
-$5.41M |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$5.3M |